• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

iShares Nasdaq Biotechnology ETF

+ Add to Watchlist

IBB:US

275.7400 USD 0.8100 0.29%

As of 15:44:41 ET on 09/02/2014.

Snapshot for iShares Nasdaq Biotechnology ETF (IBB)

Open: 278.0200 High - Low: 278.7800 - 274.8301 Primary Exchange: NASDAQ GM
Volume: 935,653 52-Week Range: 191.2903 - 278.7800 Beta vs XNBI: 1.0001

ETF Chart for IBB

No chart data available.
  • IBB:US 275.6000
  • 1D
  • 1M
  • 1Y
276.5500
Interactive IBB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for IBB

iShares Nasdaq Biotechnology ETF is an exchange-traded fund incorporated in the USA. The Fund's objective seeks investment results that correspond to the performance of the Nasdaq Biotechnology Index. The Fund will concentrate its investments in companies primarily engaged in using biomedical research for the discovery or development of new treatments or cures for human disease.

Inception Date: 2001-02-09 Telephone: 1-415-670-2000
Managers: GREG SAVAGE
Web Site: www.ishares.com

Fundamentals for IBB

NAV (on 2014-08-29) 276.5600
Assets (M) (on 2014-08-29) 5,531.2220
Shares out (M) 20.00
Market Cap (M) 5,508.00
% Premium -0.00
Average 52-Week % Premium 0.0011
Fund Leveraged N

Dividends for IBB

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net -
Dividend Yield (ttm) 0.14%

Performance for IBB

1-Month +10.25% 1-Year +42.96%
3-Month +15.60% 3-Year +42.56%
Year To Date +21.98% 5-Year +29.06%
Expense Ratio 0.48

Top Fund Holdings for IBB

Filing Date: 08/29/2014
Name Position Value % of Total
Gilead Sciences Inc 4,820,415 518,580,246 9.355%
Celgene Corp 5,116,195 486,140,849 8.770%
Amgen Inc 3,375,004 470,408,058 8.486%
Biogen Idec Inc 1,225,741 420,478,193 7.585%
Alexion Pharmaceuticals Inc 2,151,562 364,237,931 6.571%
Vertex Pharmaceuticals Inc 2,708,732 253,456,053 4.572%
Regeneron Pharmaceuticals Inc 637,651 223,509,429 4.032%
Illumina Inc 1,236,865 221,844,106 4.002%
Mylan Inc/PA 3,927,223 190,863,038 3.443%
BioMarin Pharmaceutical Inc 1,709,730 121,766,971 2.197%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil